Sort
64,565 grants matching “drug discovery”
Ultra-high-throughput plate reader for drug discovery using all-optical electrophysiology
$475,561Yang Lu · Q-State Biosciences, Inc. · R44 · FY2022 · NS
Gating and Regulation of Connexin Hemichannels
$475,537Jorge Enrique Contreras · University Of California At Davis · R01 · FY2023 · GM
Mode of Action of the Amaryllidaceae Alkaloid Lycorine-Promising Anticancer Agent
$475,519Alexander Kornienko · Texas State University · R15 · FY2014 · CA
Genetic Architecture of Cerebral Edema after Stroke
$475,501Rajat Dhar · Washington University · R01 · FY2022 · NS
Developing a computational platform for induced-fit and chemogenetic drug design
$475,500Benjamin Patrick Brown · Vanderbilt University · DP1 · FY2024 · DA
Framework to Accelerate Substance Use Disorder Genetic Studies through Customizable, EHR-Based Precision Phenotyping
$475,500Alvin Dean Jeffery · Vanderbilt University · DP1 · FY2023 · DA
Framework to Accelerate Substance Use Disorder Genetic Studies through Customizable, EHR-Based Precision Phenotyping
$475,500Alvin Dean Jeffery · Vanderbilt University · DP1 · FY2022 · DA
Novel pathways in eicosanoid biosynthesis and metabolism
$475,500Claus Schneider · Vanderbilt University · R35 · FY2023 · GM
A Highly Precise Platform Technology for Controlling Diverse Clinical Targets in Addiction
$475,500Prashant Chandra Donthamsetti · Vanderbilt University · DP1 · FY2025 · DA
Novel pathways in eicosanoid biosynthesis and metabolism
$475,500Claus Schneider · Vanderbilt University · R35 · FY2024 · GM
Novel pathways in eicosanoid biosynthesis and metabolism
$475,500Claus Schneider · Vanderbilt University · R35 · FY2022 · GM
Developing a computational platform for induced-fit and chemogenetic drug design
$475,500Benjamin Patrick Brown · Vanderbilt University · DP1 · FY2023 · DA
Developing a computational platform for induced-fit and chemogenetic drug design
$475,500Benjamin Patrick Brown · Vanderbilt University · DP1 · FY2025 · DA
Structural Genomics of Orphan Nuclear Receptors
$475,475H Eric Xu · Van Andel Research Institute · R01 · FY2010 · DK
Inducing Off-pathway Assembly of HIV Gag Polyprotein with Computationally Designed Peptides
$475,447Jose Abraham Villegas · University Of Illinois At Chicago · DP2 · FY2025 · AI
Inducing Off-pathway Assembly of HIV Gag Polyprotein with Computationally Designed Peptides
$475,447Jose Abraham Villegas · University Of Illinois At Chicago · DP2 · FY2024 · AI
Phase II Environmentally greener, efficient, and safe synthetic platform for the
$475,412Paul Matthew Herrinton · Boropharm, Inc. · R44 · FY2011 · GM
Design & Synthesis of Nonpeptide Protease Inhibitors
$475,402Arun K Ghosh · Purdue University · R37 · FY2014 · GM
Hit-to-lead discovery for sleeping sickness via industry-academic partnership
$475,385Michael P Pollastri · Northeastern University · R01 · FY2019 · AI
Hit-to-lead discovery for sleeping sickness via industry-academic partnership
$475,385Michael P Pollastri · Northeastern University · R01 · FY2016 · AI
Hit-to-lead discovery for sleeping sickness via industry-academic partnership
$475,385Michael P Pollastri · Northeastern University · R01 · FY2018 · AI
Network-based prediction and validation of causal schizophrenia genes and variants
$475,347Manolis Kellis · Broad Institute, Inc. · R01 · FY2017 · MH
Small Molecule Approaches to Targeting the DNA and RNA in Myotonic Dystrophy
$475,337Steven C. Zimmerman · University Of Illinois At Urbana-Champaign · R01 · FY2017 · AR
PPAR inhibition of spinal pain transmission
$475,267Bradley K Taylor · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · NS
Significance of UBIAD1 in Regulation of HMG CoA Reductase Degradation, Mevalonate Metabolism, and Menaquinone-4 Synthesis
$475,252Russell Alfred Debose-Boyd · Ut Southwestern Medical Center · R01 · FY2022 · GM